Ethical and financial considerations in third-party support of investigational cancer therapies.

@article{Young1993EthicalAF,
  title={Ethical and financial considerations in third-party support of investigational cancer therapies.},
  author={Frank E. Young},
  journal={Cancer},
  year={1993},
  volume={72 9 Suppl},
  pages={2854-8}
}
The appropriate use of and compensation for investigational cancer therapies raises a number of ethical, policy-related, and financial considerations. Ethical considerations include the use of therapeutic regimens for individuals versus controlled clinical trials, the extent of information necessary to indicate that a therapy may be safe and effective, and… CONTINUE READING